Results of Single-Arm, Phase 1b Study of Anti-C1q Treatment (ANX009) Show That the Classical Pathway Is a Key Driver of Complement Activation and Consumption in Patients with Active Lupus Nephritis

被引:0
|
作者
Dall'Era, Maria [1 ]
Lichauco, Juan [2 ]
Chen, Hsiang [3 ]
Gomez, Harold [4 ]
Tee, Michael [5 ,6 ]
Arroyo, Caroline [7 ]
Lan, Joung-Liang [8 ]
Fang, Yao-Fan [9 ]
Chang, Edmund [10 ]
Yousefpour, Noosha [10 ]
Low, Julian [10 ]
Bao, Min [10 ]
Chang, Qing [10 ]
Osterloh, Jeannette [10 ]
Mongan, Ann [10 ]
Yednock, Ted [10 ]
Artis, Dean [10 ]
Andrews-Zwilling, Yaisa [10 ]
Kroon, Henk-Andre [10 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA USA
[2] St Lukes Med Ctr, Quezon City, Philippines
[3] Tri Serv Gen Hosp, Taipei, Taiwan
[4] Angeles Univ Fdn, Med Ctr, Pampanga, Philippines
[5] Med Ctr Manila, Manila, Philippines
[6] Univ Philippines Manila, Manila, Philippines
[7] Iloilo Doctors Hosp, Iloilo, Philippines
[8] China Med Univ Hosp, Taichung, Taiwan
[9] Chang Gung Mem Hosp, Linkou, Taiwan
[10] Annexon Biosci, Brisbane, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2338
引用
收藏
页码:4632 / 4633
页数:2
相关论文
共 4 条
  • [1] Pathogenic Anti-C1q Antibodies Potentiate Activation of the Classical Complement Pathway in a Subset of Lupus Nephritis Patients
    Chang, Edmund
    Low, Julian
    Cahir-McFarland, Ellen
    Kroon, Henk-Andre
    Andrews-Zwilling, Yaisa
    Yednock, Ted
    Mongan, Ann
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1292 - 1294
  • [2] Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro
    Pang, Yun
    Yang, Xiao-Wei
    Song, Yan
    Yu, Feng
    Zhao, Ming-Hui
    IMMUNOBIOLOGY, 2014, 219 (12) : 980 - 989
  • [3] C1q A08 Is a Half-Cryptic Epitope of Anti-C1q A08 Antibodies in Lupus Nephritis and Important for the Activation of Complement Classical Pathway
    Wu, Wen-Jun
    Tan, Ying
    Liu, Xiao-Ling
    Yu, Feng
    Zhao, Ming-Hui
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [4] Inhibition of C1q, Initiator of the Classical Complement Cascade, by ANX005 for the Treatment of Guillain-Barre Syndrome: Results from a Phase 1b Study
    Islam, Zhahirul
    Papri, Nowshin
    Jahan, Israt
    Azad, Khan Abul Kalam
    Kroon, Henk-Andre
    Humphriss, Eric
    Sankaranarayanan, Sethu
    Yednock, Ted
    Keswani, Sanjay
    Mohammad, Quazi Deen
    NEUROLOGY, 2020, 94 (15)